Page last updated: 2024-08-21

thiazoles and Leukemia, Prolymphocytic, B-Cell

thiazoles has been researched along with Leukemia, Prolymphocytic, B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bosco, R; Capitani, S; Celeghini, C; Corallini, F; Rabusin, M; Secchiero, P; Voltan, R	1

Other Studies

1 other study(ies) available for thiazoles and Leukemia, Prolymphocytic, B-Cell

Article	Year
Anti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cells. Investigational new drugs, 2012, Volume: 30, Issue:1 Topics: Antineoplastic Agents; Apoptosis; B-Lymphocytes; Cell Line, Tumor; Cell Survival; Dasatinib; G1 Phase Cell Cycle Checkpoints; Granulocyte Precursor Cells; Humans; Leukemia, Prolymphocytic, B-Cell; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; STAT3 Transcription Factor; Thiazoles; Time Factors; Tumor Suppressor Protein p53	2012

Article

Year

Anti-leukemic activity of dasatinib in both p53(wild-type) and p53(mutated) B malignant cells.

Investigational new drugs, 2012, Volume: 30, Issue:1

Topics: Antineoplastic Agents; Apoptosis; B-Lymphocytes; Cell Line, Tumor; Cell Survival; Dasatinib; G1 Phase Cell Cycle Checkpoints; Granulocyte Precursor Cells; Humans; Leukemia, Prolymphocytic, B-Cell; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mutation; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; STAT3 Transcription Factor; Thiazoles; Time Factors; Tumor Suppressor Protein p53

2012